SPLENIC INFECTION FUNGAL

SPLENIC INFECTION FUNGAL was reported 56 times

SPLENIC INFECTION FUNGAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
1 Echinocandin Antifungal [EPC] 4 0.0005
2 Asparagine-specific Enzyme [EPC] 4 0.0003
3 Oxazolidinone Antibacterial [EPC] 8 0.0003
4 Lipid-based Polyene Antifungal [EPC] 3 0.0002
5 Topoisomerase Inhibitor [EPC] 12 0.0002
6 Penem Antibacterial [EPC] 4 0.0001
7 Lipopeptide Antibacterial [EPC] 1 0.0001
8 CD30-directed Immunoconjugate [EPC] 1 0.0001
9 Antimetabolite Immunosuppressant [EPC] 2 0.0001
10 Azole Antifungal [EPC] 14 0.0001
11 Polyene Antifungal [EPC] 3 0.0001
12 BCL-2 Inhibitor [EPC] 4 0.0001
13 Glycopeptide Antibacterial [EPC] 4 0.0001
14 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
15 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
16 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
17 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
18 Alkylating Drug [EPC] 7 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
21 Purine Antimetabolite [EPC] 2 0.0000
22 Corticosteroid [EPC] 23 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
24 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
25 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
26 Platinum-based Drug [EPC] 3 0.0000
27 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
28 Leukocyte Growth Factor [EPC] 1 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
30 Janus Kinase Inhibitor [EPC] 1 0.0000
31 Kinase Inhibitor [EPC] 2 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000